See why this broker just upgraded South32 shares to a buy

Commodity prices continue to create tailwinds for ASX stocks.

South32 Ltd (ASX: S32) shares have been popular with investors throughout 2024 and have advanced more than 10% this year.

Volatility in commodity prices and a surge in metals demand from the electrification 'megatrend' are two tailwinds behind companies like South32 in the basic materials sector.

South32 shares are trading at $3.65 each at the time of writing after a broker upgraded the miner to a buy due to recent strength in commodity prices. Here's a look.

Two smiling men in high visibility vests and yellow hardhats stand side by side with a large mound of earth and mining equipment behind them smiling as the Carnaby Resources share price rises today

Image source: Getty Images

Why UBS upgraded South32 shares

UBS has raised its earnings projections for South32 by 13% to 34% for the 2024 to 2026 financial years. This is due to higher prices for manganese and alumina – two critical metals used in the production of ceramics, gasoline, steel and aluminium.

UBS mining analyst Lachlan Shaw said the firm was bullish on South32 as prices of these metals begin to stretch higher.

"Prices across South32's commodity basket are now a strong tailwind to earnings and free cash flow optionality," Shaw told the Australian Financial Review.

At the time of writing, the price of Manganese ore has shot to 42.50 CNY/mtu from a low of 29.144 CNY/mtu on 1 January.

Meanwhile, according to the London Metals Exchange, alumina prices were USD $498 per metric tonne on 13 June, up from USD $332/mt in December 2023.

The broker has increased its price target for South32 shares to $4.15 from $3.90, which represents a 14% upside potential at the time of writing.

Other broker insights on South32

Macquarie has also shown optimism about South32 shares, especially due to its copper exposure. According to my colleague James, in late May, Macquarie reaffirmed its outperform rating on South32 shares with an upgraded price target of $4.25. This suggests a potential upside of nearly 16% based on the current share price.

Furthermore, in a May note, Goldman Sachs maintained a buy rating on South32 shares. Despite minor adjustments to its FY 2024–2026 earnings before interest, tax, depreciation, and amortisation (EBITDA) estimates, Goldman Sachs raised its 12-month price target for South32 to $4.00.

It highlighted the company's improving free cash flow (FCF) and attractive valuation. "We forecast ~US$550mn of FCF in the June half," its analysts noted. Goldman also emphasised the positive outlook for key commodities like copper, aluminium, zinc, and metallurgical coal.

South32's strong financial outlook is a key reason for these positive broker ratings, in my opinion. Higher commodity prices have significantly boosted the company's earnings and free cash flow projections, which could help fund dividends and share repurchases.

UBS's Lachlan Shaw also mentioned that a restart of the company's buyback program at the FY 2024 results "cannot be ruled out", according to the AFR.

Why South32 shares might be worth watching

The recent upgrades from UBS, Macquarie, and Goldman Sachs show a strong positive sentiment towards South32 shares.

With improved commodity prices and robust financial performance, the company might be positioned well for growth. Just remember to consider your own personal financial circumstances and to conduct your own due diligence.

Motley Fool contributor Zach Bristow has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

A little girl wearing wonky glasses checks out what's happening in the world on a mobile phone.
Broker Notes

Buy, hold, sell: Paladin Energy, Accent, Sigma Healthcare shares

Experts reveal the reasons behind their new ratings.

Read more »

A woman looks excited as she fans out a wad of Aussie $100 notes.
Broker Notes

Macquarie predicts 90% upside and an 8% dividend yield for this ASX share

If the broker is right, this share will pay off nicely.

Read more »

a doctor in white coat and stethoscope stands in front of a building holding an electronic device in his hands.
Healthcare Shares

ASX 200 healthcare shares rebound 57% in 5 months. Here's 1 to buy and 1 to sell: experts

It's time to take profits on one share, while the other has more growth left, say these experts.

Read more »

Young man with a laptop in hand watching stocks and trends on a digital chart.
Broker Notes

Buy, hold, sell: Fortescue, Santos, CBA shares

Let's review some new expert ratings and insights on 3 ASX 200 heavyweights.

Read more »

An unhappy man in a suit sits at his desk with his arms crossed staring at his laptop screen as the PointsBet share price falls
Broker Notes

BHP, Westpac, CSL shares: Buy, sell, or hold?

One of these ASX shares is tipped to fall 13%.

Read more »

Woman tying up her shoelaces before a run.
Broker Notes

Buy, hold, sell: Coles, Wesfarmers, CSL shares

It's a new week and we've got new ratings from the experts.

Read more »

a man in a business suite throws his arms open wide above his head and raises his face with his mouth open in celebration in front of a background of an illuminated board tracking stock market movements.
Broker Notes

Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

Read more »

Two male ASX investors and executives wearing dark coloured suits sit at a table holding their mobile phones discussing the highest trading ASX 200 shares today
Broker Notes

Buy, hold, sell: Resmed, Goodman Group, CBA shares

We review three fresh buy, hold, and sell calls from John Athanasiou at Red Leaf Securities.

Read more »